In comparison, the occurrence of pneumonitis related to anti-PD‐1 mAbs was slightly higher compared with anti-PD-L1 mAbs (3.6% vs. 1.3%), especially in grade 3–4 pneumonitis (1.1% vs. 0.4%) [12]. The gene discussed is CD274; the disease is pneumonitis.